A Korean premium hyaluronic acid dermal filler for facial rejuvenation, wrinkle correction, contour enhancement, and volume restoration.
MIXO is a Korean premium hyaluronic acid (HA) dermal filler manufactured by Dermakor Co., Ltd., a South Korean medical aesthetics company. It's designed for facial rejuvenation, wrinkle correction, contour enhancement, and volume restoration, and is available in both lidocaine and non-lidocaine formulations for different clinical preferences.
MIXO's main selling point produces small and uniform HA particles in a monophasic gel with a smooth consistency, high cohesiveness, and high viscoelasticity. This makes the gel easier to mold after injection, supports smooth tissue integration, reduces injection discomfort, and is designed for longer-lasting results. The manufacturer states this technology improves filler stability while maintaining natural tissue movement.
Fine wrinkles — superficial dermis
Moderate wrinkles — mid dermis
Facial contouring — deep dermis / subcutaneous
Same as above, with added lidocaine for comfort
Because these risks exist with any injectable or energy-based treatment, procedures should only be performed by trained, licensed medical professionals with expertise in facial anatomy.
MIXO is marketed internationally, and manufacturer materials indicate CE certification for certain products intended for export markets. Regulatory approval varies by country, so patients should confirm that the specific product being used is legally registered with the relevant national health authority before treatment.
MIXO is positioned as a premium Korean HA dermal filler emphasizing smooth injection, high cohesiveness, and natural-looking outcomes. Its product line covers superficial wrinkle correction through deep volumization, making it versatile for facial aesthetic procedures. While the manufacturer highlights advanced cross-linking technology and favorable handling characteristics, there is limited independent, peer-reviewed clinical evidence specifically evaluating MIXO compared with more extensively studied international filler brands. Treatment outcomes depend not only on the product itself but also on injector expertise, patient anatomy, and proper case selection.
